Holen Sie sich die Stockscreener-App
17.06
2.90%
0.48
Handel nachbörslich:
17.06
Finanzdaten der Spyre Therapeutics Inc-Aktie (SYRE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
21.71%
41.94
|
53.57 | 55.39 | 44.15 | 47.77 |
| Operating Income/Loss |
21.71%
-41.94
|
-53.57 | -55.39 | -44.15 | -47.77 |
| Nonoperating Income/Loss |
40.56%
5.218
|
8.779 | -13.62 | 5.31 | 3.949 |
| Income/Loss From Continuing Operations Before Tax |
18.02%
-36.72
|
-44.79 | -69.01 | -38.84 | -43.83 |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.015 | 0.018 | - | 0.032 |
| Income/Loss From Continuing Operations After Tax |
17.99%
-36.72
|
-44.77 | -69.03 | -38.84 | -43.86 |
Net Income/Loss
|
17.99%
-36.72
|
-44.77 | -69.03 | -38.84 | -43.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):